United Therapeutics Corporation (UTHR) Operating cash flow 2016–2025
United Therapeutics Corporation (UTHR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$1.6BFY2025 · since FY2016: $643.6M → $1.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6B | +17.6% |
| FY2024 | $1.3B | +35.7% |
| FY2023 | $978.0M | +21.9% |
| FY2022 | $802.5M | +34.2% |
| FY2021 | $598.2M | -20.8% |
| FY2020 | $755.7M | +465.8% |
| FY2019 | -$206.6M | -126.5% |
| FY2018 | $778.4M | +64.2% |
| FY2017 | $474.2M | -26.3% |
| FY2016 | $643.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More UTHR financial trends
UTHR RevenueUTHR Net incomeUTHR Net marginUTHR Gross profitUTHR Gross marginUTHR Operating incomeUTHR Operating marginUTHR Free cash flowUTHR Capital expendituresUTHR Return on equityUTHR Stock buybacksUTHR Dividends paidUTHR Total assetsUTHR Total liabilitiesUTHR Shareholders’ equityUTHR overview →